Woebot translation site

Can Woebot still be used?

It’s not possible. Woebot Health has explicitly stated that the Woebot application will be discontinued by June 30, 2025; no new accounts can be created, and existing accounts can no longer be used.

The company’s website is still operational and displays information on conversational AI health tools, technical platforms, and potential areas for collaboration with other organizations; however, this does not mean that the original consumer applications have been made available again. The old app store pages, download descriptions, and media reviews are only useful for learning about past products.

Retirement time and user data arrangement

Anonymization does not mean removing all non-personal research data or statistical information from all systems. The current FAQ only confirms that account data has been anonymized; it does not provide a list of the specific types of data that have been deleted.

What was Woebot once?

Woebot is a conversational mental health self-help application developed by Woebot Health; its founding team is led by Dr. Alison Darcy, a clinical research psychologist. It helps users learn skills to cope with everyday stress, as well as with their emotional and behavioral patterns, through short conversations, exercises, and self-observation.

The old version of this service was designed for self-service and supplementary support; it was not intended to serve as a substitute for human therapists, diagnostic tools, or emergency services. It can no longer be recommended as a mental health application that individuals can download and register for use.

Core historical functions

It is not an ordinary generative chatbot.

Woebot’s official documentation describes its core system as a rule-based conversation agent; the responses are written by conversation specialists and reviewed together with clinical experts. Natural language processing is used to understand the input and select appropriate responses crafted by experts, rather than relying on general large language models to generate every piece of advice related to mental health.

• Structured content helps maintain consistency in the logic of interventions.
• Users cannot request arbitrary open-ended tasks like a general assistant can.
• Natural language recognition may still misinterpret vague, sarcastic, or culturally specific expressions.
• The large-model experiments conducted in research are not equivalent to consumer features that have been made available online.
• It remains to be seen whether generative models will be used in future products once they are officially released.

CBT and other evidence-based frameworks

The historical versions of this product offered conversations and exercises centered on cognitive behavioral therapy; methods such as mindfulness and dialectical behavior therapy were also mentioned. The use of an evidence-based framework does not mean that the approaches will be effective for every user, nor does it constitute a clinical diagnosis or treatment.

• Identify automatic thoughts and triggering situations.
• Examine the evidence for an idea and try to express it in alternative terms.
• Break down the big goals into actionable steps.
• Record emotional changes and practice experiences.
• Turn to professional human support when needed.

Current direction of the Woebot Health Platform

The company currently describes the Woebot Health Platform as a basic development platform, whose components can be used for products that are in various stages of development and are subject to different regulatory requirements. The goal for healthcare providers is to enable patients to receive support more quickly and to reduce the additional burden on clinical staff.

• Provide supplementary support in addition to traditional medical consultations.
• Collect patient-reported outcomes and standardized scales.
• Integrate electronic medical records and care processes as required by the institution.
• Provides configurable components for payers and population health programs.
• Explore products for adults, adolescents, pregnant and nursing women, and the elderly.

These pages also highlight that different products are at various stages of development and regulation. The promotional claims made by these organizations should not be construed as indicating that the products are already available globally, suitable for all regions, or have received regulatory approval.

Current access method and price

The consumer personal application has been discontinued; there is currently no available process for personal subscriptions or direct purchases. The website only provides options for registering interest in updates and for contacting organizations, and no unified public pricing is available.

Public information does not provide details regarding the current trial period, the minimum number of members required for an organization to participate, the contract duration, refund policies, service levels, or implementation costs. Organizational purchases can only be carried out on the basis of a formal contract and a sales confirmation.

Institutional evaluation process

1. First, determine whether what is needed is health promotion, self-help support, or regulated clinical use.
2. Describe the population, region, age group, scenarios, and workflow to Woebot Health.
3. Request the specific names of the products that are currently available for deployment and their regulatory status.
4. Review whether the clinical evidence is appropriate for the target population, version, and duration of use.
5. Verify the data fields, the scope of visibility for partners, as well as the periods for cross-border transmission and storage.
6. Complete assessments for security, privacy, accessibility, procurement, and medical compliance.
7. Use small-scale projects to test participation, referral, security, and exit processes.
8. The contract specifies the procedures for service termination, data export, deletion, incident notification, and withdrawal.

The FDA identity must be properly understood.

The investigational digital therapy WB001, designed for the treatment of postpartum depression, was designated as a Breakthrough Device by the U.S. FDA in 2021. This designation is intended to speed up the communication and review process for devices that meet the criteria; it does not mean that the product has already received marketing authorization or approval.

The materials describing the current solutions also state that Woebot for Adults, Woebot for Adolescents, Woebot for Maternal Health, and Woebot for Adults 65+ have not been evaluated, licensed, or approved by the FDA. They can be used as a supplement to clinical care, but they cannot replace it.

How to interpret clinical evidence

Woebot Health has conducted and compiled a number of feasibility studies, randomized controlled trials, and studies focused on specific populations; it also emphasizes that these studies have been reviewed by institutional review boards. When evaluating the evidence, it is necessary to match the version of the study, the participants, the endpoints, the duration of the study, with the actual product in use.

• Recognition as a breakthrough device does not equate to approval for therapeutic use.
• Small sample sizes and short-term studies cannot be used to draw direct conclusions about long-term effects.
• The results for participants who chose to take part may not be applicable to the general population.
• The product version used in the research may differ from subsequent institutional versions.
• An improvement in symptom scales does not equate to clinical recovery.
• The awards listed on the marketing page cannot replace evidence from peer review.

Medical and crisis boundaries

The old terms of service defined Woebot as a self-service tool that did not provide medical, mental health, or any other professional services. It could not diagnose diseases, prescribe medications, replace therapists, or handle emergency situations.

If there is a risk of immediate harm, severe symptoms, or a mental health crisis for oneself or someone else, one should stop using messaging tools and contact the local emergency services, crisis hotlines, or qualified medical professionals immediately. Do not wait for automated responses or assume that language recognition of risks is always accurate.

What data is covered by the privacy policy?

• Account information, email address, birthday, access code, and user preferences.
• Chat content, path selection, and dialogue interactions.
• Risk-related language, user confirmation, and possible upgrade information.
• Health surveys, scales, emotional trends, and feedback on experiences.
• Equipment, operating system, crash logs, login and usage data.
• Network addresses, Cookies, pixels, and analytics data.

The policy states that personal data is not sold or shared with advertisers. Conversations may be processed in exceptional cases such as providing and improving services, or to protect users or others; in addition, organizational projects are subject to additional consent requirements and the policies of the partners involved.

Data sharing in institutional projects

Collaborative projects may involve employers, hospitals, healthcare providers, research institutions, or other partners. The policy states that specific conversations will not be shared with the project participants without the user’s consent, but anonymized or aggregated data on usage and effectiveness is usually shared.

In clinical projects or studies, responses to questionnaires, trends in emotions, or confirmations of high-risk behaviors may be shared upon consent. The way in which the collaborating parties handle this data is also governed by their own terms and conditions, privacy policies, and research consent procedures.

Data storage and anonymization of old accounts

A typical privacy policy states that personal data can be retained for as long as the user is using the service, or for the period necessary to provide services, resolve disputes, conduct audits, carry out legitimate business activities, enforce agreements, and fulfill legal obligations. It does not specify a fixed number of days for each type of data.

For applications that have been retired, the FAQ specifies that all account data will be anonymized starting from July 31, 2025. The original users have missed the deadline for requesting copies of the conversation records, and they can no longer access those records using their old accounts.

Safety measures

• User data is processed in accordance with the standards for protected health information, and HIPAA requirements are followed.
• The database is located in the AWS and Google Cloud environments in the United States.
• Static encryption is applied to the database, while TLS is used for application transmission.
• Adopt the principle of least privilege, two-factor authentication, and regular access reviews.
• Independent third-party penetration testing should be conducted at least once a year.
• Monitor maintenance logs, handle event responses, and ensure business continuity and disaster recovery plans.

These measures can help reduce risks, but neither the privacy policy nor the security page can guarantee absolute data safety. Organizations should also verify the version of the contract, the scope of the audit reports, as well as the deadlines for notifying subcontractors in case of any incidents.

Platform, API, and open-source status

Woebot used to offer its services through iOS and Android apps, but those consumer apps have been discontinued. Even if the app store pages can still be found via search engines, this does not mean that the apps can be installed, registered, or that old data can be restored.

At present, there are no official APIs, SDKs, plugins, or official GitHub repositories available for the public, nor is there any open-source licensing for this product. The Woebot Health Platform is a description of the company’s development platform; it does not mean that the code is open source or that developer interfaces are available to the public.

Who is it suitable for to pay attention now?

• Hospitals and medical systems that evaluate conversational mental health technologies.
• Professionals who study digital interventions, security, and clinical evidence.
• Seek payers and partner organizations for institutional-level population health programs.
• Users who need to know the status of their old Woebot accounts and data.
• Product teams that focus on the differences between structured session agents and generative AI.

The current usage method is not suitable.

• Consider Woebot as a personal application that can still be downloaded and registered.
• Reliance on old store pages or third-party installation packages to restore the service.
• Use chatbots to handle situations involving emergencies, self-harm, or risks of harming others.
• Refer to the approval of breakthrough devices as FDA approval.
• Replace the official evaluation of current products with the results of historical research.
• Incorporating sensitive psychological data into institutional projects without consent.

Frequently Asked Questions

Why can’t Woebot be registered?

This is because the consumer application was discontinued on June 30, 2025. The authorities no longer allow the creation of new accounts, nor is it possible to access existing accounts.

Can I also download previous Woebot conversations?

It is not possible to download it through the usual process. The deadline for requesting a copy of the conversation was July 15, 2025, and that period has already passed.

Have the data from the old account been deleted?

According to the official statement, all account data will be anonymized starting from July 31, 2025. Anonymization is different from the physical deletion of individual records, and the list of specific non-personal data has not been made public.

Is Woebot a generative large model?

The core product of its history has been rule-based session agents, whose responses are designed by writers and clinical experts. The company has researched large models, but such research does not mean that consumer products already use freely generated responses.

Has Woebot been approved by the FDA?

There is nothing on which one can claim approval. WB001 has been designated as a breakthrough device, while many products intended for various user groups are explicitly indicated as not having been evaluated, licensed, or approved by the FDA.

Can Woebot replace psychologists?

No. The old terms describe it as a self-service tool that does not provide medical or professional psychological services, nor can it handle emergency situations.

Can individuals pay to use it now?

There are no individual subscriptions available at the moment, and the consumer version of the application has been discontinued. For institutional use, it is necessary to contact the team to determine the specific product, region, and contract terms.

Is Woebot an open-source project?

Currently, there is no official publicly available source code, SDK, GitHub repository, or open-source license. The company’s Health Platform is not meant to be made available to the public under an open-source model.

How to add a FAQ Schema

This page provides the available FAQs; the site template can use these Q&A pairs to generate structured FAQ data. Script tags are not inserted directly into the text to avoid violating the security restrictions on content fields.

1. Only the questions and answers that are visible directly on the page are used.
2. The page type is set to FAQPage, and questions are of the Question type.
3. Put the answer in acceptedAnswer and set it to the Answer type.
4. The shutdown date, data date, and FDA wording must be consistent with the visible text.
5. Do not imply in structured data that the application is still available for download or registration.
6. After publication, check for grammar, repeated questions and answers, and search engine guidelines.

Summary

Woebot is a significant historical example of a conversational tool for mental health, but its consumer version has been officially discontinued. Former users can no longer log in or export their conversations, and their account data has been anonymized in accordance with official procedures.

Woebot Health continues to demonstrate its platform as well as the direction in which future health-related tools will develop; prices, the products that can be deployed, and regulatory status require verification on a case-by-case basis with the company. No AI tool for mental health can replace professional care or emergency services.